消息
×
loading..
中文版 | English

个人主页

关键词云

成果统计

合作作者[TOP 5]

  • 邱士真

    合作成果数：17

  • 范高峰

    合作成果数：12

  • 李文涛

    合作成果数：10

  • 王飞

    合作成果数：8

  • 王月桐

    合作成果数：7

访问统计


  总访问量
 3071
  访问来源
    内部： 22
    外部： 3049
    国内： 2711
    国外： 360

  年访问量
 278
  访问来源
    内部： 0
    外部： 278
    国内： 260
    国外： 18

  月访问量
 3
  访问来源
    内部： 0
    外部： 3
    国内： 3
    国外： 0

访问量

访问量

1. Genome-wide CRISPR screen identifies FAM49B as a key regulator of .. [3105]
2. Ionic CD3-Lck interaction regulates the initiation of T-cell recep.. [1408]
3. In situ conversion of defective Treg into SuperTreg cells to treat.. [1184]
4. Transcription-coupled donor DNA expression increases homologous re.. [1113]
5. Tuning charge density of chimeric antigen receptor optimizes tonic.. [878]
6. A protective AAV vaccine for SARS-CoV-2 [760]
7. THEMIS is a substrate and allosteric activator of SHP1, playing du.. [753]
8. A core epitope targeting antibody of SARS-CoV-2 [748]
9. A proximity-tagging system to identify membrane protein-protein in.. [721]
10. Chimeric Antigen Receptor Designed to Prevent Ubiquitination and D.. [567]
11. Key elements for designing and performing a CRISPR/Cas9-based gene.. [536]
12. Antigen Receptor Nanoclusters: Small Units with Big Functions [517]
13. NAD(+) supplement potentiates tumor-killing function by rescuing d.. [514]
14. PINX1 loss confers susceptibility to PARP inhibition in pan-cancer.. [502]
15. Dynamic regulation of CD28 conformation and signaling by charged l.. [500]
16. 一种泛素偶联修饰的嵌合抗原受体及免疫细胞 [486]
17. CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acu.. [479]
18. Exhaustion-associated cholesterol deficiency dampens the cytotoxic.. [454]
19. NAMPT-targeting PROTAC and nicotinic acid co-administration elicit.. [446]
20. A CRISPR-Based Toolbox for Studying T Cell Signal Transduction [434]
21. Allosterically inhibited PFKL via prostaglandin E2 withholds gluco.. [431]
22. PD-1 and BTLA regulate T cell signaling differentially and only pa.. [423]
23. Multiple Signaling Roles of CD3 epsilon and Its Application in CAR.. [400]
24. CAR trafficking does matter: prospects of 'Chimeric antigen recept.. [394]
25. Murine trophoblast organoids as a model for trophoblast developmen.. [384]
26. CHIMERIC ANTIGEN RECEPTOR MODIFIED BY UBIQUITIN COUPLING AND IMMUN.. [382]
27. Exploiting T cell signaling to optimize engineered T cell therapie.. [360]
28. CAR-Toner: an AI-driven approach for CAR tonic signaling predictio.. [357]
29. 靶向SARS-CoV-2的抗体及其制备方法和应用 [356]
30. Charging CAR by electrostatic power [344]
31. UBIQUITINATION-LACKING CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF [337]
32. NAD+和//或NAD+抑制剂和//或NAD+激动剂的用途及其联合制剂 [322]
33. 一种靶向GD2的细胞疗法及其相关应用 [320]
34. 一种靶向CD19的嵌合抗原受体及其应用 [314]
35. 一种针对高基底信号CAR-T细胞的培养基及培养方法 [306]
36. USES OF NAD+ AND//OR NAD+ INHIBITORS AND//OR NAD+ AGONISTS AND COM.. [296]
37. 一种改良的泛素化修饰缺失嵌合抗原受体及其应用 [292]
38. USES OF NAD+ AND//OR NAD+ INHIBITORS AND//OR NAD+ AGONISTS AND COM.. [276]
39. All-in-one Hangzhou Protocol: killing four birds with one stone [275]
40. Transient hydroxycholesterol treatment restrains TCR signaling to .. [272]
41. CRISPR/Cas9-Based Genetic Screening to Study T-Cell Function [267]
42. 一种泛素化缺失的嵌合抗原受体及其用途 [262]
43. Targeting cardiac fibrosis with chimeric antigen receptor macropha.. [262]
44. FAM49基因及其编码蛋白的应用 [259]
45. COMPOSITIONS AND METHODS FOR DETECTING MOLECULE-MOLECULE INTERACTI.. [258]
46. T细胞受体工程化T细胞疗法的临床研究及动物肿瘤模型的应用 [256]
47. Tonic-ing emissions and compatibility to turbocharge CAR-T [256]
48. Use of NAD+ and//or NAD+ inhibitors and // or NAD+ agonists and co.. [250]
49. B7-H3-targeted CAR-T cell therapy for solid tumors [246]
50. From suppressor to enhancer: IL-10's alternative role in CAR-T cel.. [236]
51. Ubiquitination-deficient chimeric antigen receptors and their use [227]
52. COMPOSITIONS AND METHODS FOR DETECTING MOLECULE-MOLECULE INTERACTI.. [216]
53. UBIQUITINATION-DEFICIENCY CHIMERIC ANTIGEN RECEPTOR AND USES THERE.. [212]
54. Phase separation of chimeric antigen receptor promotes immunologic.. [114]
55. Phosphotyrosine Signal Profiling of Clinical CAR-T Reveals Tonic S.. [46]
56. Tonic signaling in CAR-T therapy: the lever long enough to move th.. [3]

下载量

1. Genome-wide CRISPR screen identifies FAM49B as a key regulator of .. [780]
2. Ionic CD3-Lck interaction regulates the initiation of T-cell recep.. [373]
3. In situ conversion of defective Treg into SuperTreg cells to treat.. [371]
4. Transcription-coupled donor DNA expression increases homologous re.. [287]
5. Tuning charge density of chimeric antigen receptor optimizes tonic.. [263]
6. A protective AAV vaccine for SARS-CoV-2 [244]
7. CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acu.. [112]
8. PINX1 loss confers susceptibility to PARP inhibition in pan-cancer.. [94]
9. Chimeric Antigen Receptor Designed to Prevent Ubiquitination and D.. [27]
10. NAMPT-targeting PROTAC and nicotinic acid co-administration elicit.. [26]
11. Targeting cardiac fibrosis with chimeric antigen receptor macropha.. [18]
12. A proximity-tagging system to identify membrane protein-protein in.. [16]
13. Allosterically inhibited PFKL via prostaglandin E2 withholds gluco.. [14]
14. A core epitope targeting antibody of SARS-CoV-2 [9]
15. Murine trophoblast organoids as a model for trophoblast developmen.. [8]
16. THEMIS is a substrate and allosteric activator of SHP1, playing du.. [7]
17. All-in-one Hangzhou Protocol: killing four birds with one stone [6]
18. Key elements for designing and performing a CRISPR/Cas9-based gene.. [5]
19. CAR-Toner: an AI-driven approach for CAR tonic signaling predictio.. [5]
20. From suppressor to enhancer: IL-10's alternative role in CAR-T cel.. [5]
21. Phase separation of chimeric antigen receptor promotes immunologic.. [5]
22. COMPOSITIONS AND METHODS FOR DETECTING MOLECULE-MOLECULE INTERACTI.. [4]
23. Tonic-ing emissions and compatibility to turbocharge CAR-T [4]
24. Transient hydroxycholesterol treatment restrains TCR signaling to .. [4]
25. A CRISPR-Based Toolbox for Studying T Cell Signal Transduction [2]
26. 靶向SARS-CoV-2的抗体及其制备方法和应用 [2]
27. 一种靶向CD19的嵌合抗原受体及其应用 [2]
28. 一种改良的泛素化修饰缺失嵌合抗原受体及其应用 [2]
29. Dynamic regulation of CD28 conformation and signaling by charged l.. [1]
30. UBIQUITINATION-DEFICIENCY CHIMERIC ANTIGEN RECEPTOR AND USES THERE.. [1]
31. USES OF NAD+ AND//OR NAD+ INHIBITORS AND//OR NAD+ AGONISTS AND COM.. [1]
32. B7-H3-targeted CAR-T cell therapy for solid tumors [1]
33. T细胞受体工程化T细胞疗法的临床研究及动物肿瘤模型的应用 [1]
34. 一种靶向GD2的细胞疗法及其相关应用 [1]
35. 一种针对高基底信号CAR-T细胞的培养基及培养方法 [1]